Advertisement

Piramal Critical Care partners with Medivant Healthcare to supply injectable drugs in US

Follow The Hawk on Google News+ Follow

Advertisement


New Delhi: Piramal Critical Care on Wednesday said it has partnered with US-based pharmaceutical outsourcing facility Medivant Healthcare to address severe shortage of injectable drugs in hospitals across the United States.

Through this partnership, the company and Medivant Healthcare will work together to distribute single-dose injectable drugs in approved states for COVID-19 patients that have fallen dangerously short in supply, Piramal Critical Care said in a statement.

Advertisement

The partnership with Medivant Healthcare will leverage the company''s robust nationwide US marketing and distribution capabilities that will enable supply of single-dose injectable products to critical and sensitive markets for immediate use, Piramal Critical Care CEO Peter DeYoung said.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

"Coupling our focus on producing critical shortage medications with Piramal Critical Care''s extensive market reach, I am confident that together we will play an integral role in helping hospitals across the country alleviate these acute drug shortages," Medivant Healthcare Founder and Director Viraj Gandhi said.

Piramal Critical Care, a business unit of Piramal Enterprises, is a global leader in anesthesia, pain management, and intrathecal therapy.

—PTI

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST